AmericaFirst Quantitative Trust - AmericaFirst Defensive Growth & Income Portfolio, Series 2 »

GlaxoSmithKline shares owned by AmericaFirst Quantitative Trust - AmericaFirst Defensive Growth & Income Portfolio, Series 2

Quarter-by-quarter ownership of GlaxoSmithKline shares owned by AmericaFirst Quantitative Trust - AmericaFirst Defensive Growth & Income Portfolio, Series 2 from 13F filings

Historical chart of AmericaFirst Quantitative Trust - AmericaFirst Defensive Growth & Income Portfolio, Series 2 investment in GlaxoSmithKline

Tip: Access up to 7 years of quarterly data

All positions including GlaxoSmithKline held by AmericaFirst Quantitative Trust - AmericaFirst Defensive Growth & Income Portfolio, Series 2 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GlaxoSmithKline by AmericaFirst Quantitative Trust - AmericaFirst Defensive Growth & Income Portfolio, Series 2

Quarter filed Position value Share count Share price at filing
2017-06-30 $299k 6.9k 43.12